DRIVE
Development of Robust and Innovative Vaccines Effectiveness
Aims
To estimate brand-specific influenza vaccine effectiveness (IVE) across the EU annually.
Deliverables
To annually estimate the brand-specific effectiveness for all influenza vaccines used in the EU.
Expected Impact
To establish a sustainable network to annually estimate the brand-specific effectiveness for all influenza vaccines used in the EU.
Project outline
DRIVE is a public–private partnership launched in response to EMA guidance that requires effectiveness evaluation from manufacturers for all individual influenza vaccine brands every season. It seeks to establish a sufficiently sized network for robust, high quality, brand-specific effectiveness estimates for all influenza vaccines used in the EU each season.
The data generated through DRIVE is expected to increase the understanding of influenza vaccine effectiveness, lead to enhanced monitoring of influenza vaccine performance by public health institutes and allow manufacturers to fulfil regulatory requirements.
The DRIVE project started in 2017-18 and completed in 2022-23.
Our Team
Project Dates
2017 - 2023
Recruitment Status
Closed